ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Triple Negative Breast Neoplasms is on this study

  • ClinicalTrials.gov files the study under Triple Negative Breast Neoplasms.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Triple Negative Breast Neoplasms.
  • Rule based: the finest condition the study states.
6 links0 made here, not in the record7 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT05377996A Study of EmiltatugLedadotin (Emi-Le) inParticipants With SolidTumorsDay One Biopharmaceuticals, InPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSTriple Negative Breast Neop…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termFallopian Tube NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Adenoid CysticThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed term

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Triple Negative Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Endometrial NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Fallopian Tube NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Adenoid CysticRule based · condition-kind ruleFinest filed termCurrent
As of nowTriple Negative Breast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.